Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy

This review aims to provide a comprehensive overview of the current literature on the drug design, development, and therapy of lurasidone for the treatment of schizophrenia. Lurasidone has antagonistic effects on the dopamine D(2), 5-hydroxytryptamine (5-HT)(2A), and 5-HT(7) receptors and a partial...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Itaru, Horikoshi, Sho, Ichinose, Mizue, Suzuki, Yuhei, Watanabe, Kenya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544203/
https://www.ncbi.nlm.nih.gov/pubmed/37789971
http://dx.doi.org/10.2147/DDDT.S366769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544203/
https://www.ncbi.nlm.nih.gov/pubmed/37789971
http://dx.doi.org/10.2147/DDDT.S366769

Ejemplares similares